Gemcitabine/Cisplatin±Sorafenib for the First-Line Treatment of Chemonaive Chinese Patients with Advanced, Nonsquamous Non-Small Cell Lung Cancer (NSCLC) Subgroup Analysis of the Phase III NExUS Trial

被引：0
|
作者：
Liao, Meilin [1 ]
Zhang, Li [2 ]
Sun, Yan [3 ]
Yu, Shiying [3 ]
Pan, Hongming [4 ]
Zhou, Caicun
Jiang, Anastasia
Montegriffo, Elaine
Ong, Teng Jin
Gatzemeier, Ulrich [5 ]
机构：
[1] Shanghai Chest Hosp, Clin Med Ctr Lung Tumor, Dept Pulm Oncol, Shanghai, Peoples R China
[2] Sun Yat Sen Univ, Dept Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[3] Tongji Hosp, Dept Oncol, Shanghai, Peoples R China
[4] Sir Run Run Shaw Hosp, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Hosp Grosshansdorf, Dept Thorac Oncol, Grosshansdorf, Germany
来源：
JOURNAL OF THORACIC ONCOLOGY | 2010年 / 5卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S374 / S374
页数：1
相关论文
共 50 条
  • [41] BIOMARKER ANALYSIS OF A RANDOMIZED, CONTROLLED, MULTICENTER CLINICAL TRIAL COMPARING PEMETREXED/CISPLATIN AND GMCITABINE/CISPLATIN AS FIRST-LINE TREATMENT FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER
    Zhang, Li
    Huang, Yan
    Hu, Zhihuang
    Liu, Yun-Peng
    Zhou, Jianying
    Xu, Nong
    Li, Baolan
    Wu, Gang
    Liu, Xiaoqing
    Fang, Jian
    Li, Kai
    Wei, Liu
    Lu, You
    Wang, Meng-Zhao
    Liu, Wenzhao
    Liang, Houjie
    Zhang, Yiping
    Huang, Cheng
    Wang, Shunjin
    Wang, Yajie
    Yu, Shiying
    Chang, Jianhua
    Wang, Zhehai
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S330 - S330
  • [42] Results of a Phase I/II Trial of Amrubicin (AMR) in Combination with Cisplatin (CDDP) as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC)
    Hattori, Yoshihiro
    Yamamoto, Nobuyuki
    Ichinose, Yukito
    Negoro, Shunichi
    Hida, Toyoaki
    Takeda, Koji
    Masuda, Noriyuki
    Nakagawa, Kazuhiko
    Yokota, Soichiro
    Fukuoka, Masahiro
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S386 - S386
  • [43] Results of a phase I/II trial of amrubicin (AMR) in combination with cisplatin (CDDP) as a first-line treatment in patients with advanced non-small cell lung cancer (NSCLC)
    Seto, T.
    Ichinose, Y.
    Yamamoto, N.
    Kaira, K.
    Negoro, S.
    Hida, T.
    Takeda, K.
    Masuda, N.
    Yokota, S.
    Fukuoka, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [44] PROSPECTIVE PHASE II TRIAL OF A COMBINATION OF GEMCITABINE AND UFT AS FIRST-LINE TREATMENT IN ELDERLY PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER
    Baek, J. H.
    Kim, H.
    Kim, H. J.
    Park, J.
    Min, Y. J.
    ANNALS OF ONCOLOGY, 2010, 21 : 157 - 157
  • [45] Innovations: Randomized phase II trial of erlotinib (E)/bevacizumab (B) compared with cisplatin (P)/gemcitabine (G) plus B in first-line treatment of advanced nonsquamous (NS) non-small cell lung cancer (NSCLC)
    Thomas, M.
    Reuss, A.
    Fischer, J. R.
    Andreas, S.
    Kortsik, C.
    Grah, C.
    Serke, M. H.
    von Eiff, M.
    Witt, C.
    Kollmeier, J.
    Mueller, E.
    Mueller, L.
    Schenk, M.
    Heine, R.
    Behringer, D. M.
    Schroeder, M.
    Reinmuth, N.
    Schnabel, P.
    Acker, T.
    Wolf, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [46] ACTIVITY AND TOLERABILITY OF CARBOPLATIN AND GEMCITABINE IN FIRST-LINE TREATMENT OF ELDERLY THAI PATIENTS WITH ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC)
    Charoentum, Chaiyut
    Theerakittikul, Theerakorn
    Saeteng, Somcharone
    Euathrongchit, Juntima
    Lertprasertsuke, Nirush
    Ariyawutyakorn, Witthawat
    Chewaskulyong, Busyamas
    Thongprasert, Sumitra
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1313 - S1313
  • [47] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-Line Treatment in Elderly Patients with Advanced Non-Small Cell Lung Cancer
    Baek, Jin Ho
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Park, Chang Ryul
    Lee, Yong Jik
    Cha, Hee Jeong
    Kwon, Woon Jung
    Noh, Young Ju
    Min, Young Joo
    JOURNAL OF THORACIC ONCOLOGY, 2010, 5 (12) : S400 - S400
  • [48] Prospective Phase II Trial of a Combination of Gemcitabine and UFT as First-line Treatment in Elderly Patients With Advanced Non-small Cell Lung Cancer
    Baek, J.
    Ahn, J.
    Jegal, Y.
    Park, C.
    Lee, Y.
    Cha, H.
    Kwon, W.
    Noh, Y.
    Park, J.
    Min, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S621 - S621
  • [49] Docetaxel in combination with Gemcitabine as first-line treatment of patients with inoperable, locally advanced or metastatic non-small cell lung cancer (NSCLC)
    Barata, Fernando
    Sousa, Amelia
    Camacho, Elvira
    Costa, Marco S.
    Canario, Dolores
    Nogueira, Fernando
    Semedo, Eulalia
    ANNALS OF ONCOLOGY, 2004, 15 : 179 - 179
  • [50] Prospective phase II trial of a combination of gemcitabine and UFT as first-line treatment in elderly patients with advanced non-small cell lung cancer
    Baek, Jin Ho
    Kim, Hawk
    Ahn, Jong-Joon
    Jegal, Yangjin
    Seo, Kwang Won
    Ra, Seung Won
    Park, Chang Ryul
    Jung, Jong Pil
    Kim, Jeong Won
    Lee, Yong Jik
    Cha, Hee Jeong
    Kwon, Woon Jung
    Noh, Young Ju
    Oh, Sukjoong
    Park, Jae-Hoo
    Min, Young Joo
    LUNG CANCER, 2012, 76 (03) : 368 - 372
12345